Burden of Respiratory Syncytial Virus Infection in Children and Older Patients Hospitalized with Asthma: A Seven-Year Longitudinal Population-Based Study in Spain
- PMID: 39599863
- PMCID: PMC11599133
- DOI: 10.3390/v16111749
Burden of Respiratory Syncytial Virus Infection in Children and Older Patients Hospitalized with Asthma: A Seven-Year Longitudinal Population-Based Study in Spain
Abstract
(1) Background: To describe hospitalizations due to respiratory syncytial virus (RSV) infection among children and elderly patients with asthma. (2) Methods: We used a nationwide discharge database to select patients with asthma aged 0 to 15 years and ≥65 years admitted to Spanish hospitals from 2016 to 2022. (3) Results: We identified 49,086 children and 471,947 elderly patients hospitalized with asthma (3.52% and 0.51%, respectively, with RSV). The proportion of RSV increased over time in children with asthma (from 1.44% to 7.4%, p < 0.001) and in elderly individuals (from 0.17% to 1.01%, p < 0.001). Among children with RSV infection, the presence of influenza (OR 3.65; 95% CI 1.46-9.1) and pneumonia (OR 1.85; 95% CI 1.02-3.55) increased the risk of poor outcome. The presence of RSV was associated with severity in these patients, defined by use of mechanical ventilation and/or admission to the intensive care unit (OR 1.44; 95% CI 1.11-1.86). In elderly patients with RSV infection, older age, congestive heart failure, COVID-19, and pneumonia increased the risk of in-hospital mortality (IHM). However, RSV infection was not associated with IHM (OR 0.88; 95% CI 0.68-1.15) in these patients. (4) Conclusion: Our results highlight the impact of RSV infection in children and elderly patients hospitalized with asthma. Strategies to improve surveillance, prophylaxis, and management of RSV infection should be evaluated.
Keywords: asthma; children; elderly patients; hospital admissions; respiratory syncytial virus.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Ruiz-Galiana J., Cantón R., De Lucas Ramos P., García-Botella A., García-Lledó A., Hernández-Sampelayo T., Gómez-Pavón J., del Castillo J.G., Martín-Delgado M.C., Sánchez F.J.M., et al. Respiratory syncytial virus: A new era. Rev. Esp. Quimioter. 2024;37:134–148. doi: 10.37201/req/147.2023. - DOI - PMC - PubMed
-
- Patel D.A., Marcum Z.A., Chansakul A., Toyip A., Nerney K., Panozzo C.A., Laurent S.S., Mehta D., Ghaswalla P. Economic burden of cardiorespiratory hospitalizations associated with respiratory syncytial virus among United States adults in 2017–2019. Hum. Vaccin. Immunother. 2024;20:2364493. doi: 10.1080/21645515.2024.2364493. - DOI - PMC - PubMed
-
- Mazela J., Jackowska T., Czech M., Helwich E., Martyn O., Aleksiejuk P., Smaga A., Glazewska J., Wysocki J. Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years. Viruses. 2024;16:704. doi: 10.3390/v16050704. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- the Madrid Government (Comunidad de Madrid-Spain) under the Multiannual Agreement with Universidad Complutense de Madrid in the line Excellence Programme for university teaching staff, in the context of the V PRICIT (Regional Programme of Research and Tec
- 970970/Universidad Complutense de Madrid, Grupo de Investigación en Epidemiología de las Enfermedades Crónicas de Alta Prevalencia en España GEPIECAP-
LinkOut - more resources
Full Text Sources
Medical
